AMP Working Group Recommends Alleles to Include in Warfarin Sensitivity Genotyping Assays
The group said the recommendations aim to standardize and improve warfarin response genotyping assays.
Study Reports Fewer Dose Adjustments With PGx-Guided Warfarin Versus Standard Care in Asian Patients
The study, involving 322 patients from China, India, and Malaysia, is the largest randomized evaluation of warfarin PGx in Asian patients, the authors said.
Study Provides 'Strong Evidence' Backing Warfarin Initiation PGx Testing; Adoption Impact Unclear
The large PGx analysis might provide welcome data for those already supportive of genotyping in the context of warfarin, but will it convince detractors?
Study Shows Exclusion of Relevant Genotypes Causes Warfarin PGx Failure in African Americans
A study has demonstrated why dosing algorithms for warfarin have performed poorly in patients with African ancestry, especially in recent randomized clinical trials.
Genome British Columbia Backs Regional Project to Study Benefits of Pharmacist-guided PGx Testing
NEW YORK (GenomeWeb) – A new project spearheaded by Genome British Columbia and the BC Pharmacy Association (BCPhA) aims to assess whether pharmacists can drive adoption of genetic testing among doctors and help provide patients greater access to personalized medicine.
Feb 3, 2010